Delivery Order SPE2DB20D1100-SPE2DB25FA6L0

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,433.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PIRFENIDONE 267 MG TABLET 90S, a pharmaceutical product, with a performance period ending on February 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $38,353.62 firm fixed-price delivery order is for the supply of 4560843693 PIRFENIDONE 801 MG TABLET 90S. The contract has an ultimate completion date of May 8, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $9,445.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4565684035 - PIRFENIDONE 801 MG TABLET 90S, a pharmaceutical product, with a completion date of September 5, 2024. The contract is a Delivery Order on a Firm Fixed Price basis and does not have a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, will be the prime contractor responsible for...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,701.45 firm fixed-price delivery order is for the supply of 4564703640 Pirfenidone 801 mg tablets, with a performance period through May 24, 2024. This contract was not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Pirfenidone 267 mg tablets. The $20,327.43 firm fixed-price delivery order contract has a completion date of June 6, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,893.12 firm fixed-price delivery order is for the supply of Pirfenidone 267 mg tablets. The contract has an ultimate completion date of November 15, 2023 and was awarded on November 14, 2023 with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,440.79, is for the delivery of 4566594653 - Pirfenidone 801 mg Tablets, 90-count, and does not have a set-aside designation. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a...
This federal contract award, valued at $1,246.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pirfenidone 801 mg tablets, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) and has a ceiling value of $3,329.25. The contract is for the delivery of Pirfenidone 801 mg tablets and is designated as a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of November 29, 2024 and was awarded on November 27, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $14,491.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566932515 Pirfenidone 801 mg tablets, a medication used to treat a specific medical condition. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 15, 2025. It is not designated as a set-aside...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA6L0
    Delivery Order

This federal contract award, valued at $1,529.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567278092 PIRFENIDONE 267 MG TABLET 90S and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/16/25, 12:06 PM